Commentary: Why “tri” to repair the valve if it will just “lead” to recurrent regurgitation?

Abstract

Life-threatening arrhythmias after congenital heart surgery that require cardiac rhythm devices remain a challenging management problem for many patients. In this report from Huang and colleagues,1 the authors examine mid-term results of the surgical management of transvenous lead-induced tricuspid regurgitation. The authors determine that there are similar rates of survival and reintervention on the tricuspid valve between the valve repair and valve replacement cohorts during their follow-up period.